- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bioceltix SA (BCXP)
Bioceltix SA stock price live, this page displays WA BCXP stock exchange data. View the BCXP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bioceltix SA real time stock price chart below.
What Is the Bioceltix SA Stock Price Today?
The Bioceltix SA stock price today is 92.60.
What Is the Stock Symbol for Bioceltix SA?
The stock symbol for Bioceltix SA is "BCXP."
What Stock Exchange Does Bioceltix SA Trade On?
Bioceltix SA is listed and trades on the Warsaw stock exchange.
Is Bioceltix SA a Good Stock to Buy?
Determining whether Bioceltix SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BCXP quote. (ISIN: PLBCLTX00019)
What Is the Bioceltix SA Stock Price Today?
The Bioceltix SA stock price today is 92.60.
What Is the Stock Symbol for Bioceltix SA?
The stock symbol for Bioceltix SA is "BCXP."
What Stock Exchange Does Bioceltix SA Trade On?
Bioceltix SA is listed and trades on the Warsaw stock exchange.
Is Bioceltix SA a Good Stock to Buy?
Determining whether Bioceltix SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BCXP quote. (ISIN: PLBCLTX00019)
92.60
-0.90(-0.96%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
91.30
94.00
52 wk Range
70.00
111.00
BCXP is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
91.3094.00
52 wk Range
70.00111.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
BCXP Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
133.00
Upside
+43.63%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 133.00
(+43.63% Upside)
Earnings
Latest Release
May 29, 2026
EPS / Forecast
-1.03 / --
Revenue / Forecast
-- / --
Compare BCXP to Peers and Sector
Metrics to compare | BCXP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBCXPPeersSector | |
|---|---|---|---|---|
P/E Ratio | −30.1x | −3.9x | −0.4x | |
PEG Ratio | 2.73 | −0.01 | 0.00 | |
Price/Book | 7.6x | 2.7x | 2.6x | |
Price / LTM Sales | - | 4.4x | 3.0x | |
Upside (Analyst Target) | 43.6% | 43.5% | 50.8% | |
Fair Value Upside | Unlock | 9.7% | 9.4% | Unlock |
Bioceltix S.A. engages in the development of veterinary biologics based on mesenchymal stem cells. The company’s products include BCX-CM-J, a stem-cell based medicinal drug for the treatment of osteoarthritis in dogs; BCX-CM-AD, an allogeneic stem cell-based medicinal product for the treatment of atopic dermatitis in dogs; and BCX-EM, an allogeneic stem cell-based medicinal product for the treatment of osteoarthritis in horses. It also develops BCX-CM-Sec, a research project aimed at developing a cell-free biological drug to treat atopic dermatitis in dogs. The company was founded in 2016 and is headquartered in Wroclaw, Poland.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Bioceltix (BCXP) Stock Price Today?
The Bioceltix stock price today is 92.60 PLN.
What Stock Exchange Does Bioceltix Trade On?
Bioceltix is listed and trades on the Warsaw Stock Exchange.
What Is the Stock Symbol for Bioceltix?
The stock symbol for Bioceltix is "BCXP."
What Is the Bioceltix Market Cap?
As of today, Bioceltix market cap is 512.29M PLN.
What Is Bioceltix's Earnings Per Share (TTM)?
The Bioceltix EPS (TTM) is -3.31.
When Is the Next Bioceltix Earnings Date?
Bioceltix will release its next earnings report on Sep 23, 2026.
From a Technical Analysis Perspective, Is BCXP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Bioceltix Stock Split?
Bioceltix has split 0 times.
How Many Employees Does Bioceltix Have?
Bioceltix has 46 employees.
What is the current trading status of Bioceltix (BCXP)?
As of Jul 18, 2026, Bioceltix (BCXP) is trading at a price of 92.60 PLN, with a previous close of 93.50 PLN. The stock has fluctuated within a day range of 91.30 PLN to 94.00 PLN, while its 52-week range spans from 70.00 PLN to 111.00 PLN.
What Is Bioceltix (BCXP) Price Target According to Analysts?
The average 12-month price target for Bioceltix is 133.00 PLN, with a high estimate of 133 PLN and a low estimate of 133 PLN. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +43.63% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.